Pharma Biz Denies Infringing Rival's Blood Pressure Patent
Roma Pharmaceuticals has fought back against claims that it infringed SyriMed's blood pressure treatment patent, claiming that its rival should not have received protections because the drug was not new....To view the full article, register now.
Already a subscriber? Click here to view full article